Last update: June 30, 2015
Moderately safe. Probably compatible.
Mild risk possible. Follow up recommended.
Read the Comment.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Azelastine belongs to these groups or families:
Main tradenames from several countries containing Azelastine in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 40 | % |
Molecular weight | 418 | daltons |
Protein Binding | 80 - 90 | % |
VD | 15 | l/Kg |
Tmax | 2 - 5 | hours |
T1/2 | 22 - 35 | hours |
Write to us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second generation anti-histaminic drug with low sedative effect. Used for ophthalmic and nasal topical administration.
On last update no relevant published data related to breastfeeding were found.
A small dose together with a low plama level of most nasal and ophthalmologic compounds make that a significant excretion into breast milk would be unlikely.